Health Care/Life Sciences – Bluegrass Direct News

Johnson & Johnson Covid-19 Vaccine Pause Disrupts Appointments in New York Region

04/13/2021 Bluegrass Direct News appointments, Biotechnology, Clothing, Clothing/Textiles, Consumer Goods, COVID, covid vaccine, COVID19, disrupts, Domestic Politics, Epidemics, Executive Branch, general news, Government Bodies, health, health care, Health Care/Life Sciences, Health/Social Services Department, Immunizations, Infectious Diseases, international relations, JNJ, Johnson, Johnson & Johnson, life sciences, Medical Conditions, medical treatments, Medical Treatments/Procedures, medications, Meningitis, Novel Coronaviruses, outbreaks, Outbreaks/Epidemics, Pause, Pharmaceuticals, political, Political/General News, Politics, Politics/International Relations, procedures, region, Regional Politics, Respiratory Tract Diseases, social services department, specialized drugs, Specialized Drugs/Medications, SYND, Textiles, vaccine, vaccines, WSJ-PRO-WSJ.com, York

Thousands of Covid-19 vaccination appointments had to be rescheduled across the tri-state region Tuesday after governors said they would pause

J&J Vaccine Clot Issue Shows Limits of Clinical Trials, Scientists Say

04/13/2021 Bluegrass Direct News Adverse Drug Reactions, C&E Industry News Filter, clinical, Clot, Content Types, corporate, Corporate/Industrial News, development, Epidemics, Factiva Filters, general news, health, health care, Health Care/Life Sciences, Immunizations, industrial news, Infectious Diseases, issue, JNJ, Johnson & Johnson, life sciences, limits, Medical Conditions, medical treatments, Medical Treatments/Procedures, medications, new product, New Product/Service Testing, new products, New Products/Services, Novel Coronaviruses, outbreaks, Outbreaks/Epidemics, Pharmaceuticals, political, Political/General News, procedures, products, Products/Services, research, Research/Development, Respiratory Tract Diseases, Scientists, service testing, services, Shows, specialized drugs, Specialized Drugs/Medications, SYND, trials, vaccine, vaccines, WSJ-PRO-WSJ.com

WASHINGTON—Clinical trials are medicine’s way of deciding whether vaccines and drugs work, and how safe they are. But the studies

Business unusual: wearable tech, touchless surfaces and office ‘mud rooms’

04/12/2021 Bluegrass Direct News article_normal, arts, Basketball, business, Business/Consumer Services, C&E Exclusion Filter, C&E Industry News Filter, Casinos, computers, Computers/Consumer Electronics, construction, Construction/Real Estate, Consumer Electronics, Consumer Products, consumer services, Content Types, corporate, Corporate/Industrial News, cre commercial-real-estate, Factiva Filters, health care, Health Care/Life Sciences, hospitality, hotels, Hotels/Restaurants/Casinos, industrial news, Internet, Internet/Online Services, labor, Labor/Personnel, leisure, Leisure/Arts/Hospitality, life sciences, Mud, office, online services, Personal Electronics, personnel, Pharmaceuticals, Real Estate, Restaurants, Rooms, Routine General News, Sports, surfaces, Tech, Technology, Telecommunication Services, Touchless, Unusual, Wearable, Wearable Technology, Wireless Telecommunications Services

Still in the teeth of a deadly pandemic, the NBA’s San Antonio Spurs started the season on Dec. 23 with

Covid-19 Drug Prevents Symptomatic Disease in Study, Regeneron Says

04/12/2021 Bluegrass Direct News Biopharmaceuticals, Biotechnology, C&E Industry News Filter, Content Types, corporate, Corporate/Industrial News, COVID19, disease, drug, Epidemics, Factiva Filters, government policy, health, health care, Health Care/Life Sciences, Immunizations, industrial news, Infectious Diseases, life sciences, Medical Conditions, medical treatments, Medical Treatments/Procedures, National Institute of Allergy and Infectious Diseases, Novel Coronaviruses, outbreaks, Outbreaks/Epidemics, Pharmaceuticals, Prevents, procedures, Regeneron, Regeneron Pharmaceuticals, REGN, regulation, Regulation/Government Policy, Respiratory Tract Diseases, Study, symptomatic, WSJ-PRO-WSJ.com

An antibody drug from Regeneron Pharmaceuticals Inc. reduced the risk of developing symptomatic Covid-19 infection by 81% compared with a

CEOs Plan New Push on Voting Legislation

04/11/2021 Bluegrass Direct News AMC, AMC Entertainment Holdings Cl A, American Express, asset management, Automotive, AXP, Banking, Banking/Credit, beverages, Beverages/Drinks, C&E Industry News Filter, CEOs, Consumer Goods, Content Types, corporate, Corporate/Industrial News, credit, CyberCore Technologies, drinks, Electronic Payment Systems, Estée Lauder, Factiva Filters, Financial Investment Services, Financial Services, Financial Technology, food, Food/Beverages, Fund, General Labor Issues, general news, HD, health care, Health Care/Life Sciences, Home Depot, industrial news, INVESTING, Investing/Securities, kwexclusive, Legislation, life sciences, management, Merck, Mobile Payment Systems, Motor Vehicles, MRK, non-alcoholic beverages, Non-alcoholic Beverages/Drinks, Passenger Cars, Pharmaceuticals, plan, political, Political/General News, Portfolio, Portfolio/Fund/Asset Management, push, SBUX, securities, Soft Drinks, Starbucks, SYND, Technology, voting, WSJ-PRO-WSJ.com

Dozens of chief executives and other senior leaders gathered on Zoom this weekend to plot what several said big businesses

2 Companies That Raised Their Dividends This Week

04/04/2021 Bluegrass Direct News C&E Exclusion Filter, C&E Industry News Filter, companies, Content Types, corporate, Corporate Actions, Corporate/Industrial News, Digital Content Services, DIVIDENDS, Earnings, Entertainment, Factiva Filters, Financial Performance, GL, Globe Life, health care, Health Care/Life Sciences, industrial news, life sciences, Markets, McCormick, Media, Media Content Distribution, Media/Entertainment, MKC, Multimedia Content Services, North America, Online Service Providers, Pharmaceuticals, Raised, Real Estate, S&P 500 INDEX, Simon Property Group, SPG, SPX, SYND, Technology, TJX, week

Text size Simon Property Group said it plans to maintain its quarterly dividend at $1.30 a share. David Williams/Bloomberg Insurance

Airlines Want Vaccine Passports but Don’t Want to Pay for Them

04/03/2021 Bluegrass Direct News AF.FR, Air France-KLM, Air France-KLM Group, Air Transport, AIRLINES, corporate, Corporate/Industrial News, Deutsche Lufthansa, dont, Epidemics, European Union, general news, health, health care, Health Care/Life Sciences, Human Migration, IAG.LN, Immunizations, industrial news, Infectious Diseases, International Consolidated Airlines Group S.A., international relations, LHA.XE, life sciences, logistics, Medical Conditions, medical treatments, Medical Treatments/Procedures, medications, Novel Coronaviruses, outbreaks, Outbreaks/Epidemics, Passenger Airlines, Passports, Pay, Pharmaceuticals, political, Political/General News, Politics, Politics/International Relations, procedures, Respiratory Tract Diseases, specialized drugs, Specialized Drugs/Medications, SYND, Thomas Reynaert, transportation, Transportation/Logistics, vaccine, vaccines, WSJ-PRO-WSJ.com, XE:LHA

LONDON—Airlines are resisting early European Union plans that could push some of the costs and responsibility for implementing vaccination passports

Experimental Immunoglobulin Covid-19 Therapies Fail Testing

04/03/2021 Bluegrass Direct News 4502, 4502.TO, Biopharmaceuticals, Biotechnology, business, Business/Consumer Services, clinical, consumer services, COVID19, CSL Behring, diagnostic services, EBS, Emergent Biosolutions, Epidemics, experimental, Fail, general news, GILD, Gilead Sciences, GRF.MC, GRFS, Grifols, health, health care, Health Care/Life Sciences, Healthcare Support Services, Immunoglobulin, Infectious Diseases, life sciences, Medical, Medical Conditions, Medical Research Services, Medical/Clinical/Diagnostic Services, Novel Coronaviruses, outbreaks, Outbreaks/Epidemics, Pharmaceuticals, political, Political/General News, Respiratory Tract Diseases, Scientific Research Services, SYND, Takeda Pharmaceutical, testing, Therapies, WSJ-PRO-WSJ.com

Four experimental Covid-19 treatments derived from the blood of recovered patients failed in testing, the drugmakers said. The therapies from

FDA Probes Cause of Failed Johnson & Johnson Covid-19 Vaccine Batch

04/02/2021 Bluegrass Direct News batch, C&E Industry News Filter, Content Types, contracts, Contracts/Orders, corporate, Corporate/Industrial News, COVID19, EBS, Emergent Biosolutions, Epidemics, Factiva Filters, failed, FDA, Food and Drug Administration, general news, government policy, health, health care, Health Care/Life Sciences, Immunizations, industrial news, Infectious Diseases, JNJ, Johnson, Johnson & Johnson, life sciences, Medical Conditions, medical treatments, Medical Treatments/Procedures, medications, non-government contracts, Non-Government Contracts/Orders, Novel Coronaviruses, orders, outbreaks, Outbreaks/Epidemics, Pharmaceuticals, political, Political/General News, Probes, procedures, regulation, Regulation/Government Policy, Respiratory Tract Diseases, specialized drugs, Specialized Drugs/Medications, standardization, standards, Standards/Standardization, SYND, vaccine, vaccines, WSJ-PRO-WSJ.com

The Food and Drug Administration is investigating what caused a batch of the active ingredient for Johnson & Johnson ’s

FTC Challenges Illumina’s Planned Acquisition of Liquid-Biopsy Firm Grail

03/30/2021 Bluegrass Direct News acquisition, acquisitions, Acquisitions/Mergers, Acquisitions/Mergers/Shareholdings, Anti-Competition Issues, Biotechnology, C&E Executive News Filter, C&E Industry News Filter, cancer, Cancer Drugs, challenges, Content Types, corporate, Corporate Actions, corporate crime, Corporate Crime/Legal Action, Corporate/Industrial News, Factiva Filters, Federal Trade Commission, firm, FTC, general news, Genomics, Grail, health, health care, Health Care/Life Sciences, Illumina, Illuminas, ILMN, industrial news, legal action, life sciences, LiquidBiopsy, Medical Conditions, medications, mergers, Ownership Changes, Pharmaceuticals, planned, political, Political/General News, shareholdings, specialized drugs, Specialized Drugs/Medications, SYND, Telecommunication Services, WSJ-PRO-WSJ.com

WASHINGTON—The Federal Trade Commission filed a lawsuit Tuesday that seeks to block Illumina Inc.’s planned $7.1 billion acquisition of a

← Previous